AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Greater openness is needed to stop drug firms from distorting the truth by selectively releasing--and therefore controlling--the publication of drug study results, say leading medical journal editors. And they intend to do something about it.
In a joint editorial, editors of prominent medical journals told researchers and pharmaceutical firms to register their trials in public databases before starting them. That means that later on, unflattering results cannot be buried.
Drug firms are known to ...